HEALTH● LOWJul 8 · Jul 8, 2026, 1:31 PM
Healthy Returns: Employers aren't expanding coverage of GLP-1 obesity drugs – many are finding ways around it
CNBC
Around 36% of employers said they provide coverage of GLP-1s for both diabetes and weight loss, the same as 2025 and up from 34% in 2024, the survey said.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH32m agoWhy the world’s first spinal cord transplant is so controversialNew ScientistHEALTH32m agoFG disburses N249.6bn health fund in three years, targets 17,600 facilitiesPremium TimesHEALTH1h agoChristina Applegate left with health questions after revealing MS misdiagnosisCBS NewsHEALTH1h agoLagos begins mandatory health insurance enforcement January 2027Vanguard Nigeria